secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001104659-25-016345
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio to present at Leerink Partners Global Healthcare Conference on March 11, 2025
--------------------------------------------------------------------------------

- Members of senior leadership will participate in a fireside chat on Tuesday, March 11, 2025 at 1:40 p.m. ET.
- Live webcast and replay will be available on the News & Events page of Zura Bio's website for at least 30 days.
- Zura Bio is a clinical-stage immunology company developing dual-pathway antibodies for autoimmune diseases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/0001104659-25-016345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/tm257217d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-016345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer